Billiontoone Inc (BLLN) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Billiontoone Inc   (NASDAQ: BLLN)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Billiontoone Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Billiontoone Inc's ROI in the second quarter of 2026?
Billiontoone Inc achieved a return on average invested assets (ROI) of 6.12 % in its second quarter of 2026, this is above BLLN's average return on investment of 0%.
Billiontoone Inc invested over the 12 months ending in its second quarter of 2026 $547 million

Despite the deterioration in its net income, company has improved ROI compared to the first quarter of 2026.

Within the Healthcare sector Billiontoone Inc achieved the highest return on investment. While the total ranking for ROI remained the same, compared to the first quarter of 2026 at no. .

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 844.1 % - - - -
Y / Y Net Income Change TTM -95.91 % -96.93 % 4.49 % - -
Investment (TTM) in Millions 674 644 585 287 232
Return On Investment (TTM) 6.12 % 5.77 % 153.24 % 633.39 % 1414.11 %
BLLN's Overall Ranking # # # # #
Seq. Investment Change TTM 25.31 % 58.33 % 112.75 % 123.67 % -
Seq. Net Income Change TTM 32.93 % -94.04 % -48.53 % 0.18 % -0.03 %
Net Income (TTM) in Millions 34 25 423 821 820

BLLN Company Profile >> Back to BLLN Roi Comparisons >> See Annual BLLN Return On Investment



Return On Investment BLLN's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Billiontoone Inc's II. Quarter Investments $ 674 Millions BLLN's Balance sheet
Billiontoone Inc's II. Quarter Income $ 8 Millions Quarterly BLLN's Income Statement
BLLN's Income by Division See BLLN's Income by Division


BLLN Annual Return On Investment (Dec 31 2025)
2025



Total Investments in Millions 585 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions 3 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 0.5 % - - - -


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 0.5 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BLLN's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BLLN's Competitors
Subscribers only: Roi for Billiontoone Inc's Suppliers
Subscribers only: Return On Investment for BLLN's Customers

Other Ratios
BLLN's Roa BLLN's Inventory Turnover Ratio BLLN's Growth Rates BLLN's Dividend Statistics
BLLN's Profitability Ratios BLLN's Asset Turnover Ratio BLLN's Dividend Growth
BLLN's Roe BLLN's Valuation Ratios BLLN's Financial Strength Ratios BLLN's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %
Aveanna Healthcare Holdings Inc   16.32 %
Harmony Biosciences Holdings inc   15.85 %
Entera Bio Ltd   15.84 %
Nephros Inc   15.31 %
West Pharmaceutical Services Inc   15.29 %
Progyny Inc   15.25 %
Biolife Solutions Inc   14.83 %
Sbc Medical Group Holdings Incorporated  14.78 %
Spero Therapeutics Inc   14.54 %
Insulet Corporation  14.30 %
Alpha Pro Tech Ltd   13.80 %
Bristol myers Squibb Company  13.58 %
Transmedics Group Inc   13.46 %
Strata Critical Medical Inc   13.34 %
Johnson and Johnson  13.30 %
Amgen Inc   13.08 %
Medinotec Inc   13.06 %
Lantheus Holdings Inc   13.02 %
Msa Safety Inc  13.02 %
Universal Health Services Inc   12.43 %
Ufp Technologies Inc   12.12 %
Solventum Corporation  11.98 %
Ligand Pharmaceuticals Incorporated  11.93 %
Lifevantage Corp  11.84 %
Regeneron Pharmaceuticals Inc   11.83 %
Protagonist Therapeutics inc   11.66 %
Encompass Health Corporation  11.56 %
Embecta Corp   11.20 %

Date modified: 2026-09-08T15:11:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.